Serine/Threonine TGF b Signalling & Hormone Basics
Serine/Threonine Receptor Kinases – Focus on the TGF-β Pathway
Context & Scope
Last receptor-kinase “type” covered (others already include receptor tyrosine kinases, etc.).
Several additional signalling pathways will be discussed later, but no new receptor-kinase “families.”
Dual Nature of TGF-β Family Ligands
TGF-β family ligands can either activate or inhibit cell functions depending on the responding cell-type.
Instructor will revisit this nuance during cell-cycle lectures.
Canonical “Activation” Outcomes (when TGF-β is stimulatory)
Cell proliferation.
Apoptosis (programmed cell death) – controlled removal of cells.
Cell specialization / differentiation (e.g., “little cell” → neuron).
Crucial roles in embryonic development because of extensive differentiation requirements.
Receptor Architecture & Early Signal Steps
Two distinct transmembrane serine/threonine kinase receptors participate:
Type I receptor (purple tail in slide).
Type II receptor.
Ligand binding choreography
Both receptors bind the same TGF-β ligand simultaneously.
The Type II receptor is constitutively active → phosphorylates the Type I receptor.
Activated Type I receptor then phosphorylates cytoplasmic R-SMAD proteins.
SMAD Cascade & Nuclear Events
Phosphorylated R-SMAD (referred to as “R SMAD” in lecture) dimerizes with SMAD4.
The R-SMAD/SMAD4 complex translocates to the nucleus → modulates transcription of target genes.
Cancer-Related Mutations in TGF-β & Other Growth-Factor Pathways
General point: Disruptions in growth-factor signalling are oncogenic.
First oncogene discovered: a mutation in the gene (historical landmark).
EGF-receptor (RTK) mutations
Associated cancers: breast carcinoma, glioblastoma (glial-cell tumors), fibrosarcoma (long-bone connective-tissue tumors).
TGF-β pathway lesion statistics
Type I receptor mutations present in of ovarian cancers.
Type II receptor mutations linked to colorectal cancers.
SMAD4 mutations observed in of pancreatic cancers.
Implication: Proper serine/threonine receptor-kinase signalling is critical for cell-cycle regulation and controlled cell division.
Hormone Fundamentals (Preview for Upcoming Pathways)
Production, Circulation & Half-Life
Hormones are synthesized in endocrine glands → released into bloodstream.
Once in blood, lifetime varies widely:
Epinephrine (adrenaline): seconds (short bursts; avoids prolonged “fight-or-flight”).
Insulin: hours (sustained glycaemic control).
Steroid hormones (lipid-based): potentially days (due to carrier proteins & lipid solubility).
“Target” Cell Definition
A tissue is a target tissue for a hormone if its cells possess the specific receptor for that hormone → receptor presence = responsiveness.
Broad Chemical Categories of Hormones
Amino-acid–based / peptide / protein hormones.
Lipid-based hormones (steroids derived from cholesterol).
Adrenergic Hormones (brief mention)
Instructor alludes to upcoming detail on adrenergic hormones (epinephrine, norepinephrine) that bind adrenergic receptors; specifics to follow in later slides.
Key Terms & Concepts (Quick Reference)
Serine/Threonine Receptor Kinase: Receptor whose cytoplasmic domain phosphorylates substrates on serine or threonine residues.
TGF-β (Transforming Growth Factor-β): Multifunctional cytokine family with context-dependent effects.
R-SMAD: Receptor-regulated SMAD (direct substrate of Type I receptor).
SMAD4: Common-mediator SMAD that partners with R-SMAD.
Apoptosis: Programmed cell death; contrasted with necrosis.
Oncogene: Mutated gene promoting cancer (e.g., ).
Conceptual Connections & Significance
The TGF-β/SMAD pathway illustrates how serine/threonine receptor kinases translate extracellular cues into gene-expression programs.
Cross-talk with other pathways (RTKs, GPCRs) coordinates proliferation vs. differentiation vs. apoptosis.
Mutational hotspots in receptors or SMADs underscore therapeutic targets in oncology (e.g., SMAD4 status guiding pancreatic cancer prognosis).
Hormone signalling efficiency depends on circulation half-life, receptor distribution, and downstream kinase cascades (setting the stage for GPCR, cAMP, and PKC pathways in subsequent lectures).
Practical & Philosophical Takeaways
Precision matters: A single phosphorylation event cascade can decide between life, death, or differentiation of a cell.
Context matters: The same ligand (TGF-β) may activate or inhibit based on cellular context.
Therapeutic angle: Understanding receptor-kinase pathways opens doors to targeted cancer treatments (e.g., kinase inhibitors, monoclonal antibodies against mutated receptors).